Provided by Tiger Trade Technology Pte. Ltd.

Alnylam Pharmaceuticals

236.22
+6.923.02%
Post-market: 236.480.2586+0.11%19:58 EDT
Volume:1.91M
Turnover:449.27M
Market Cap:31.52B
PE:42.04
High:238.97
Open:228.88
Low:228.34
Close:229.30
52wk High:495.55
52wk Low:197.81
Shares:133.43M
Float Shares:133.16M
Volume Ratio:1.16
T/O Rate:1.43%
Dividend:- -
Dividend Rate:- -
EPS(TTM):5.62
EPS(LYR):2.33
ROE:96.55%
ROA:12.34%
PB:23.28
PE(LYR):101.38

Loading ...

NASDAQ Top and Bottom Performing Stocks at About 02:45 P.m. EDT on 2026-08-21

Reuters
·
Yesterday

Movement Alert|Alnylam Pharmaceuticals Rises 5.75% in After-Hours Trading, Trading at $232.0

Market Focus
·
Aug 21

Lowered TTR Sales Outlook And Legal Probe Might Change The Case For Investing In Alnylam (ALNY)

Simply Wall St.
·
Aug 21

Movement Alert|Alnylam Pharmaceuticals Falls 5.07% in Regular Trading, Trading at $229.555

Market Focus
·
Aug 21

NASDAQ Top and Bottom Performing Stocks at About 11:01 A.m. EDT on 2026-08-20

Reuters
·
Aug 20

Movement Alert|Alnylam Pharmaceuticals Rises 5.06% in Regular Trading, Trading at $238.57

Market Focus
·
Aug 19

Alnylam Pharmaceuticals Shares up 5.2% After Bmo Initiates Coverage with Outperform Rating

THOMSON REUTERS
·
Aug 19

Alnylam Pharmaceuticals Initiated at Outperform by BMO Capital

Dow Jones
·
Aug 19

Alnylam Pharma (ALNY) Gets a Hold from Wells Fargo

TIPRANKS
·
Aug 14

U.S. Research Roundup-Cisco, Fox Corp, Target

Reuters
·
Aug 14

Alnylam Pharma (ALNY) Receives a Buy from Stifel Nicolaus

TIPRANKS
·
Aug 13

Is Alnylam’s Mixed 2026 Guidance Reset Altering The Investment Case For Alny (ALNY)?

Simply Wall St.
·
Aug 12

Movement Alert|Alnylam Pharmaceuticals Falls 5.04% in Regular Trading, Continued Pressure After Q2 Guidance Cut

Market Focus
·
Aug 07

Tenaya Therapeutics Q2 Net Loss Widens on Impairment Charge

Reuters
·
Aug 06

Tenaya Net Loss Widens to $43.39 Million in Q2 FY26; R&D Expenses Slip to $16.6 Million

Reuters
·
Aug 06

NASDAQ Top and Bottom Performing Stocks at About 11:01 A.m. EDT on 2026-08-05

Reuters
·
Aug 05

H.C. Wainwright Sticks to Its Buy Rating for Alnylam Pharma (ALNY)

TIPRANKS
·
Aug 04

Alnylam Pharmaceuticals is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Aug 04

Alnylam Pharmaceuticals, Inc. : H.c. Wainwright Cuts Target Price to $455 from $485

THOMSON REUTERS
·
Aug 04

U.S. Research Roundup-Cloudflare, Replimune, Walmart

Reuters
·
Aug 04